Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
247.45
Dollar change
+0.92
Percentage change
0.37
%
IndexS&P 500 P/E58.53 EPS (ttm)4.23 Insider Own0.14% Shs Outstand290.39M Perf Week2.41%
Market Cap71.49B Forward P/E17.24 EPS next Y14.35 Insider Trans-0.90% Shs Float288.49M Perf Month3.47%
Income1.22B PEG6.77 EPS next Q2.97 Inst Own89.59% Short Float0.97% Perf Quarter2.04%
Sales19.49B P/S3.67 EPS this Y6.08% Inst Trans-1.90% Short Ratio1.90 Perf Half Y-4.39%
Book/sh87.68 P/B2.82 EPS next Y10.81% ROA2.47% Short Interest2.79M Perf Year2.58%
Cash/sh4.28 P/C57.84 EPS next 5Y8.65% ROE5.13% 52W Range229.85 - 287.32 Perf YTD1.48%
Dividend Est.3.74 (1.51%) P/FCF27.00 EPS past 5Y52.43% ROI3.09% 52W High-13.88% Beta0.43
Dividend TTM3.72 (1.50%) Quick Ratio0.64 Sales past 5Y4.18% Gross Margin41.37% 52W Low7.65% ATR (14)4.07
Dividend Ex-DateMar 07, 2024 Current Ratio1.08 EPS Y/Y TTM-21.92% Oper. Margin11.83% RSI (14)61.82 Volatility1.58% 1.62%
Employees73000 Debt/Eq0.64 Sales Y/Y TTM2.59% Profit Margin6.25% Recom1.69 Target Price277.58
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q-43.38% Payout73.72% Rel Volume0.75 Prev Close246.53
Sales Surprise-0.56% EPS Surprise11.66% Sales Q/Q2.62% EarningsFeb 01 BMO Avg Volume1.47M Price247.45
SMA203.60% SMA503.50% SMA200-2.00% Trades Volume1,093,910 Change0.37%
Date Action Analyst Rating Change Price Target Change
Jul-24-23Upgrade Raymond James Mkt Perform → Outperform $305
May-30-23Resumed Morgan Stanley Overweight $295
May-05-23Upgrade Piper Sandler Neutral → Overweight $260 → $290
Apr-12-23Upgrade KeyBanc Capital Markets Sector Weight → Overweight $304
Jan-03-23Upgrade BofA Securities Neutral → Buy $250 → $290
Dec-12-22Upgrade Citigroup Sell → Neutral $221 → $250
Jul-11-22Downgrade Citigroup Neutral → Sell $265 → $235
Jun-24-22Upgrade Wells Fargo Equal Weight → Overweight $275
Mar-18-22Resumed Raymond James Mkt Perform
Mar-02-22Resumed BofA Securities Neutral $290
Mar-27-24 06:50AM
Mar-26-24 09:31AM
Mar-21-24 07:05AM
06:57AM
06:50AM
06:50AM Loading…
Mar-18-24 06:50AM
Mar-14-24 01:00PM
11:57AM
Mar-13-24 04:30PM
06:50AM
Mar-12-24 10:34AM
Mar-06-24 05:05AM
Mar-05-24 08:28AM
Mar-04-24 05:35PM
07:37AM
06:50AM Loading…
06:50AM
Feb-29-24 05:26AM
Feb-27-24 01:28PM
06:50AM
Feb-26-24 09:18AM
Feb-23-24 11:14AM
Feb-21-24 06:45AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
Feb-13-24 12:07PM
Feb-12-24 04:43PM
Feb-06-24 10:28AM
Feb-05-24 12:23AM
Feb-02-24 08:52AM
12:17AM
12:01AM Loading…
12:01AM
Feb-01-24 01:11PM
10:35AM
10:01AM
09:30AM
07:40AM
07:20AM
07:03AM
06:36AM
06:30AM
Jan-31-24 11:52AM
Jan-30-24 06:45AM
Jan-29-24 10:49AM
09:16AM
Jan-25-24 10:29AM
10:00AM
06:45AM
Jan-23-24 04:15PM
06:45AM
Jan-10-24 06:45AM
Jan-05-24 04:15PM
Jan-04-24 04:15PM
Dec-22-23 07:00AM
Dec-14-23 03:06AM
Dec-12-23 07:00AM
Dec-11-23 06:55AM
Dec-08-23 02:15PM
06:17AM
Dec-07-23 09:08AM
07:17AM
07:01AM
06:50AM
Dec-06-23 05:09AM
Dec-05-23 02:18PM
Dec-04-23 04:15PM
05:10AM
Dec-01-23 04:10PM
Nov-30-23 06:27PM
01:04PM
06:50AM
Nov-22-23 12:13AM
Nov-21-23 06:50AM
Nov-14-23 04:15PM
Nov-12-23 11:42PM
Nov-10-23 02:31PM
02:31PM
01:39PM
12:01AM
Nov-09-23 05:21PM
04:58PM
02:05PM
01:17PM
11:17AM
10:51AM
09:30AM
07:56AM
07:05AM
06:52AM
06:30AM
06:25AM
Nov-06-23 12:12PM
09:48AM
Nov-02-23 10:00AM
06:50AM
Oct-25-23 04:15AM
Oct-23-23 06:32AM
Oct-20-23 02:41PM
Oct-18-23 01:08PM
Oct-17-23 08:46AM
Oct-16-23 04:35PM
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spoerel Thomas JSVP,Controller&Chief Acct OffMar 14 '24Sale238.2928267,1982,276Mar 15 02:19 PM
Garrison Michael DavidEVP & President MedicalDec 11 '23Sale232.461,239288,0187,274Dec 12 04:31 PM
Byrd RichardEVP & President InterventionalNov 28 '23Sale238.472,156514,1414,120Nov 29 07:27 PM
Goette RolandEVP and President, EMEANov 16 '23Option Exercise107.123,544379,63317,164Nov 20 02:20 PM
Byrd RichardEVP & President InterventionalSep 05 '23Sale274.48459125,9863,444Sep 06 09:32 AM
Fraser ClaireDirectorAug 28 '23Sale281.66848238,84821,608Aug 30 08:48 AM
Hickey DavidEVP & President, Life SciencesAug 11 '23Option Exercise132.543,883514,6539,030Aug 14 04:40 PM
Hickey DavidEVP & President, Life SciencesAug 11 '23Sale277.852,974826,3264,199Aug 14 04:40 PM
Garrison Michael DavidEVP & President MedicalAug 08 '23Sale277.131,300360,2695,157Aug 09 02:41 PM